Pembrolizumab Improves Survival for Some Patients with Advanced Non-Small Cell Lung Cancer
A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1071558/syndication
- Syndication ID: 16567
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Tuesday, January 24, 2017 at 10:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM
Embed Code Snippet
To get the embed code snippet please Login.
